We are live on ! Find out more
CSC

Caldwell Sutter Capital Portfolio holdings

AUM $246M
1-Year Est. Return 23.62%
This Fund
S&P 500
This Quarter Est. Return
+1.03%
1 Year Est. Return
+23.62%
3 Year Est. Return
+65.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215M
AUM Growth
+$318K
Cap. Flow
+$3.46M
Cap. Flow %
1.61%
Top 10 Hldgs %
22%
Holding
930
New
23
Increased
123
Reduced
156
Closed
32

Top Buys

Rank Stock Value
1
EQC
Equity Commonwealth
EQC
+$2.78M
2
AAPL icon
Apple
AAPL
+$459K
3
WM icon
Waste Management
WM
+$441K
4
V icon
Visa
V
+$331K
5
BCLI
BRAINSTORM CELL THERAPUTC
BCLI
+$290K

Top Sells

Rank Stock Value
1
KNTK icon
Kinetik
KNTK
+$689K
2
ORCL icon
Oracle
ORCL
+$400K
3
DVN icon
Devon Energy
DVN
+$284K
4
COST icon
Costco
COST
+$238K
5
PFE icon
Pfizer
PFE
+$231K

Sector Composition

Rank Sector Weight
1 Financials 23.7%
2 Technology 12.63%
3 Industrials 11.97%
4 Consumer Staples 7.48%
5 Energy 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KHC icon
551
Kraft Heinz
KHC
$32.9B
$9.83K ﹤0.01%
320
+176
+122% +$5.77K
DBC icon
552
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$9.69K ﹤0.01%
453
+73
+19% +$1.63K
EFT
553
Eaton Vance Floating-Rate Income Trust
EFT
$283M
$9.62K ﹤0.01%
750
– –
IWO icon
554
iShares Russell 2000 Growth ETF
IWO
$14.3B
$9.5K ﹤0.01%
33
– –
YUMC icon
555
Yum China
YUMC
$15.8B
$9.49K ﹤0.01%
197
– –
WEC icon
556
WEC Energy
WEC
$36.3B
$9.4K ﹤0.01%
100
– –
ISRG icon
557
Intuitive Surgical
ISRG
$127B
$9.39K ﹤0.01%
18
– –
IJS icon
558
iShares S&P Small-Cap 600 Value ETF
IJS
$8.21B
$9.34K ﹤0.01%
86
– –
COF icon
559
Capital One
COF
$130B
$9.27K ﹤0.01%
52
– –
EMXC icon
560
iShares MSCI Emerging Markets ex China ETF
EMXC
$22.7B
$9.26K ﹤0.01%
167
– –
TT icon
561
Trane Technologies
TT
$99.8B
$9.23K ﹤0.01%
25
– –
IJR icon
562
iShares Core S&P Small-Cap ETF
IJR
$110B
$9.1K ﹤0.01%
79
– –
AMBA icon
563
Ambarella
AMBA
$3.28B
$9.09K ﹤0.01%
125
-100
-44% -$6.37K
CMCSA icon
564
Comcast
CMCSA
$88.1B
$9.04K ﹤0.01%
241
+30
+14% +$1.25K
BSX icon
565
Boston Scientific
BSX
$68.7B
$8.93K ﹤0.01%
100
– –
VRTX icon
566
Vertex Pharmaceuticals
VRTX
$124B
$8.86K ﹤0.01%
22
– –
CLDX icon
567
Celldex Therapeutics
CLDX
$2.91B
$8.85K ﹤0.01%
350
– –
MCK icon
568
McKesson
MCK
$105B
$8.55K ﹤0.01%
15
– –
RIVN icon
569
Rivian
RIVN
$24.1B
$8.54K ﹤0.01%
642
+165
+35% +$1.9K
IWS icon
570
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
$8.41K ﹤0.01%
65
– –
WBA
571
DELISTED
Walgreens Boots Alliance
WBA
$8.4K ﹤0.01%
900
– –
USTB icon
572
Victory Portfolios II VictoryShares Short-Term Bond ETF
USTB
$2.29B
$8.33K ﹤0.01%
166
– –
CUZ icon
573
Cousins Properties
CUZ
$5.38B
$8.27K ﹤0.01%
270
– –
NVR icon
574
NVR
NVR
$17.3B
$8.18K ﹤0.01%
1
– –
ZTS icon
575
Zoetis
ZTS
$32.6B
$8.15K ﹤0.01%
50
– –
21 22
23
24 25

Similar funds

RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
HA
Hanover Advisors Seneca, South Carolina $246M AUM 12.74% 1-Year Est. Return
DB
Dravo Bay Rehoboth Beach, Delaware $246M AUM 15.09% 1-Year Est. Return
PPA
Pilgrim Partners Asia Singapore $246M AUM
HWM
HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return

Caldwell Sutter Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Caldwell Sutter Capital held 930 positions worth $215M, up 0.15% from $215M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Caldwell Sutter Capital's Q4 2024 filing shows 23 new, 123 increased, 156 reduced and 32 closed positions. Its largest new stake was BRAINSTORM CELL THERAPUTC: 157,009 shares worth $0. The largest sale was Kinetik, an estimated $689K.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Caldwell Sutter Capital's largest Q4 2024 buy was BRAINSTORM CELL THERAPUTC: 157,009 shares worth $0.
  • Caldwell Sutter Capital added most to Equity Commonwealth in Q4 2024, an estimated $2.78M increase.
  • Caldwell Sutter Capital's biggest Q4 2024 reduction was Kinetik, cutting an estimated $689K.
  • Caldwell Sutter Capital fully exited Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares in Q4 2024, selling an estimated $106K.
  • Caldwell Sutter Capital's ten largest holdings make up 22% of its $215M portfolio in Q4 2024.
  • Caldwell Sutter Capital opened 23 new positions and closed 32 in Q4 2024.
  • Caldwell Sutter Capital's portfolio value rose 0.15% quarter-over-quarter to $215M.

Based on Caldwell Sutter Capital's 13F filing for Q4 2024, filed 21 Jan 2025.